(a) Medication donated as part of the Surplus Medication Program may be handled in the following ways:
(1) Dispensed to an eligible patient.
(2) Destroyed.
(3) Returned to a Reverse Distributor or licensed waste hauler.
(4) Transferred to another Participating Entity within the City, after which it shall be dispensed to an eligible patient, destroyed, or returned to a Reverse Distributor or licensed waste hauler. Medication transferred pursuant to this subsection (a)(4) shall be transferred with documentation that identifies the drug name, strength, and quantity of the Medication, and the donation facility from where the Medication originated shall be identified on Medication packaging or in accompanying documentation. A copy of all documentation required under the previous sentence shall be kept by the Participating Entity transferring the Medication and the Participating Entity receiving the Medication.
(b) Medication donated as part of the Surplus Medication Program shall be maintained in the donated packaging units until dispensed to an eligible patient under the program, who presents a valid prescription. When dispensed, the Medication shall be in a new and properly labeled container, specific to the eligible patient and ensuring the privacy of the individual for whom the Medication was initially dispensed.
(c) Medication donated as part of the Surplus Medication Program shall be physically segregated from the Participating Entity’s other drug stock, for purposes of inventory, accounting, and inspection.
(d) Medication donated under this Article 43 in opened containers shall not be dispensed, and once identified, shall be quarantined immediately and handled and disposed of in accordance with the Medical Waste Management Act (Part 14 (commencing with Section 117600) of Division 104 of the California Health and Safety Code).
(e) A Participating Entity shall follow the same procedural drug pedigree requirements for donated drugs as it would follow for drugs purchased from a wholesaler or directly from a drug manufacturer.
(Added by Ord. 247-18, File No. 180804, App. 10/26/2018, Eff. 11/26/2018)